Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Peripheral blood alive cell treatment is effective and safe for treating hair loss.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Early hair loss may indicate prostate issues.

PRP may help treat hair loss, but results vary.

Polyglutamic acid is a valuable, sustainable ingredient for skincare and haircare products.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

PRP therapy increases hair density for androgenetic alopecia.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Mechanical stress contributes to hair loss in androgenetic alopecia.

The peach gene CTG134 helps control the interaction between auxin and ethylene, which could lead to new agricultural chemicals.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

PRP and LLLT can improve hair growth in AGA, but more research needed.

AGA affects many, progresses differently, and early treatment is crucial.

Standardized PRP therapy can improve treatment for hair loss.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

PRP treatment increased hair density, especially in men and younger patients with AGA.

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

New treatments for common hair loss are needed.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Early hair loss may indicate future prostate issues.

Hair loss may indicate higher risk of heart disease.

People with androgenetic alopecia have a higher risk of heart disease.

Stem cell treatment improved life quality and sexual function in women with hair loss.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.